British Journal of Cancer - Table of Contents alert Volume 113 Number 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 113, Issue 9 (1249-1404) Published online 3 November 2015 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Introducing THE DARWIN CANCER BLOG — "keeping an evolutionary eye on cancer" led by Prof. Mel Greaves and brought to you by BJC. This blog provides a forum for discussing how an evolutionary perspective is changing thinking about cancer and aims to encourage discussion and debate among specialists and general interest readers. »Start reading the latest content   Minireview Top Upcoming translational challenges for uveal melanoma Amirouchene-Angelozzi Nabil, Schoumacher Marie, Stern Marc-Henri, Cassoux Nathalie, Desjardins Laurence, Piperno-Neumann Sophie, Lantz Olivier and Roman-Roman Sergio Br J Cancer 2015 113: 1249-1253; advance online publication, October 27, 2015; 10.1038/bjc.2015.269 Abstract | Full Text Clinical Studies Top Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum David M Gershenson, Charlotte C Sun and Kwong-Kwok Wong Br J Cancer 2015 113: 1254-1258; advance online publication, October 20, 2015; 10.1038/bjc.2015.364 Abstract | Full Text Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark Matejka Rebolj, Johanne Rask, Marjolein van Ballegooijen, Benny Kirschner, Kirsten Rozemeijer, Jesper Bonde, Carsten Rygaard and Elsebeth Lynge Br J Cancer 2015 113: 1259-1274; advance online publication, October 8, 2015; 10.1038/bjc.2015.339 Abstract | Full Text The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma Anna Wilkins, Andrew Furness, Richard W Corbett, Adam Bloomfield, Nuria Porta, Stephen Morris, Zohra Ali, James Larkin and Kevin Harrington Br J Cancer 2015 113: 1275-1281; advance online publication, October 20, 2015; 10.1038/bjc.2015.357 Abstract | Full Text Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI J Guo, J O Glass, M B McCarville, B L Shulkin, V M Daryani, C F Stewart, J Wu, S Mao, J R Dwek, L M Fayad, J E Madewell, F Navid, N C Daw and W E Reddick Br J Cancer 2015 113: 1282-1288; advance online publication, October 13, 2015; 10.1038/bjc.2015.351 Abstract | Full Text Translational Therapeutics Top Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis Alison Roos, Laura Satterfield, Shuying Zhao, Daniel Fuja, Ryan Shuck, M John Hicks, Lawrence A Donehower and Jason T Yustein Br J Cancer 2015 113: 1289-1297; advance online publication, October 15, 2015; 10.1038/bjc.2015.305 Abstract | Full Text Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone J Carrasco, M Gizzi, G Pairet, V Lannoy, P Lefesvre, J-F Gigot, C Hubert, A Jouret-Mourin, Y Humblet, J-L Canon, C Sempoux, X Chapaux, E Danse, N Tinton, B Navez and M Van den Eynde Br J Cancer 2015 113: 1298-1304; advance online publication, October 13, 2015; 10.1038/bjc.2015.321 Abstract | Full Text Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma Nadeera De Silva, Laura Schulz, Anna Paterson, Wendi Qain, Maria Secrier, Edmund Godfrey, Heok Cheow, Maria O'Donovan, Pierre Lao-Sirieix, Minesh Jobanputra, Daniel Hochhauser, Rebecca Fitzgerald and Hugo Ford Br J Cancer 2015 113: 1305-1312; advance online publication, October 20, 2015; 10.1038/bjc.2015.342 Abstract | Full Text RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs B Beuselinck, J Jean-Baptiste, G Couchy, S Job, A De Reynies, P Wolter, C Théodore, G Gravis, B Rousseau, L Albiges, S Joniau, V Verkarre, E Lerut, J J Patard, P Schöffski, A Méjean, R Elaidi, S Oudard and J Zucman-Rossi Br J Cancer 2015 113: 1313-1322; advance online publication, October 13, 2015; 10.1038/bjc.2015.352 Abstract | Full Text Molecular Diagnostics Top Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma Kimio Shinoda, Satoshi Kuboki, Hiroaki Shimizu, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Katsunori Furukawa and Masaru Miyazaki Br J Cancer 2015 113: 1323-1331; advance online publication, October 13, 2015; 10.1038/bjc.2015.272 Abstract | Full Text Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion Anne-Marie Byrne, Spiros Bekiaris, Gina Duggan, David Prichard, Murat Kirca, Stephen Finn, John V Reynolds, Dermot Kelleher and Aideen Long Br J Cancer 2015 113: 1332-1342; advance online publication, October 13, 2015; 10.1038/bjc.2015.350 Abstract | Full Text Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer Benjamin Goeppert, Lena Frauenschuh, Manuela Zucknick, Stephanie Roessler, Arianeb Mehrabi, Mohammadreza Hafezi, Albrecht Stenzinger, Arne Warth, Anita Pathil, Marcus Renner, Peter Schirmacher and Wilko Weichert Br J Cancer 2015 113: 1343-1349; advance online publication, October 13, 2015; 10.1038/bjc.2015.337 Abstract | Full Text Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers Hanna M Romanska, Piotr Potemski, Magdalena Krakowska, Magdalena Mieszkowska, Shalini Chaudhri, Radzisław Kordek, Robert Kubiak, Valerie Speirs, Andrew M Hanby, Rafał Sadej and Fedor Berditchevski Br J Cancer 2015 113: 1350-1357; advance online publication, September 29, 2015; 10.1038/bjc.2015.344 Abstract | Full Text Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients Xiaodan Meng, Simon A Joosse, Volkmar Müller, Fabian Trillsch, Karin Milde-Langosch, Sven Mahner, Maria Geffken, Klaus Pantel and Heidi Schwarzenbach Br J Cancer 2015 113: 1358-1366; advance online publication, September 22, 2015; 10.1038/bjc.2015.340 Abstract | Full Text Epidemiology Top Lung cancer risk at low radon exposure rates in German uranium miners M Kreuzer, N Fenske, M Schnelzer and L Walsh Br J Cancer 2015 113: 1367-1369; advance online publication, September 22, 2015; 10.1038/bjc.2015.324 Abstract | Full Text Residential exposure to extremely low-frequency magnetic fields and risk of childhood leukaemia, CNS tumour and lymphoma in Denmark Camilla Pedersen, Christoffer Johansen, Joachim Schüz, Jørgen H Olsen and Ole Raaschou-Nielsen Br J Cancer 2015 113: 1370-1374; advance online publication, October 20, 2015; 10.1038/bjc.2015.365 Abstract | Full Text The impact of patient comorbidity on cancer stage at diagnosis Jason Gurney, Diana Sarfati and James Stanley Br J Cancer 2015 113: 1375-1380; advance online publication, October 13, 2015; 10.1038/bjc.2015.355 Abstract | Full Text Impact of alcohol drinking on gastric cancer development according to Helicobacter pylori infection status Seung-Hyun Ma, Woohyun Jung, Elisabete Weiderpass, Jieun Jang, Yunji Hwang, Chunghyun Ahn, Kwang-Pil Ko, Soung-Hoon Chang, Hai-Rim Shin, Keun-Young Yoo and Sue K Park Br J Cancer 2015 113: 1381-1388; advance online publication, September 17, 2015; 10.1038/bjc.2015.333 Abstract | Full Text Serum lactate dehydrogenase and survival following cancer diagnosis Wahyu Wulaningsih, Lars Holmberg, Hans Garmo, Håkan Malmstrom, Mats Lambe, Niklas Hammar, Göran Walldius, Ingmar Jungner, Tony Ng and Mieke Van Hemelrijck Br J Cancer 2015 113: 1389-1396; advance online publication, October 15, 2015; 10.1038/bjc.2015.361 Abstract | Full Text International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data J Cohen, L Pivodic, G Miccinesi, B D Onwuteaka-Philipsen, W A Naylor, D M Wilson, M Loucka, A Csikos, K Pardon, L Van den Block, M Ruiz-Ramos, M Cardenas-Turanzas, Y Rhee, R Aubry, K Hunt, J Teno, D Houttekier and L Deliens Br J Cancer 2015 113: 1397-1404; advance online publication, September 1, 2015; 10.1038/bjc.2015.312 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.